These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22749922)

  • 1. Risk, worry and cosmesis in decision-making for contralateral risk-reducing mastectomy: analysis of 60 consecutive cases in a specialist breast unit.
    Beesley H; Holcombe C; Brown SL; Salmon P
    Breast; 2013 Apr; 22(2):179-184. PubMed ID: 22749922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The psychosocial impact of contralateral risk reducing mastectomy (CRRM) on women: A rapid review.
    Collins K; Gee M; Clack A; Wyld L
    Psychooncology; 2018 Jan; 27(1):43-52. PubMed ID: 28453892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes to contralateral risk reducing mastectomy among breast and plastic surgeons in England.
    Basu NN; Littlechild S; Barr L; Ross GL; Evans DG
    Ann R Coll Surg Engl; 2016 Feb; 98(2):121-7. PubMed ID: 26741657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).
    Kiely BE; Jenkins MA; McKinley JM; Friedlander ML; Weideman P; Milne RL; McLachlan SA; Hopper JL; Phillips KA
    Breast Cancer Res Treat; 2010 Apr; 120(3):715-23. PubMed ID: 19669874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessment.
    Mai PL; Lagos VI; Palomares MR; Weitzel JN
    Ann Surg Oncol; 2008 Dec; 15(12):3415-21. PubMed ID: 18836779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
    Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Costa D; Musiello T; Marven M; Butow P
    Breast; 2017 Feb; 31():233-240. PubMed ID: 27969575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of age on the breast surgery decision-making process.
    Bleicher RJ; Abrahamse P; Hawley ST; Katz SJ; Morrow M
    Ann Surg Oncol; 2008 Mar; 15(3):854-62. PubMed ID: 18058182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing surgical treatment decisions for breast cancer: a qualitative exploration of surgeon and patient perspectives.
    Dicks E; Roome R; Chafe J; Powell E; McCrate F; Simmonds C; Etchegary H
    Curr Oncol; 2019 Apr; 26(2):e216-e225. PubMed ID: 31043830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast surgeons' perceptions and attitudes towards contralateral prophylactic mastectomy.
    Musiello T; Bornhammar E; Saunders C
    ANZ J Surg; 2013 Jul; 83(7-8):527-32. PubMed ID: 23043449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warranting the decision-maker, not the decision: How healthcare practitioners evaluate the legitimacy of patients' unprompted requests for risk-reducing mastectomy.
    Brown SL; Beesley H; Holcombe C; Saini P; Salmon P
    Patient Educ Couns; 2019 Aug; 102(8):1446-1451. PubMed ID: 30922623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis.
    Heemskerk-Gerritsen BA; Rookus MA; Aalfs CM; Ausems MG; Collée JM; Jansen L; Kets CM; Keymeulen KB; Koppert LB; Meijers-Heijboer HE; Mooij TM; Tollenaar RA; Vasen HF; ; Hooning MJ; Seynaeve C
    Int J Cancer; 2015 Feb; 136(3):668-77. PubMed ID: 24947112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Manchester guidelines for contralateral risk-reducing mastectomy.
    Basu NN; Ross GL; Evans DG; Barr L
    World J Surg Oncol; 2015 Aug; 13():237. PubMed ID: 26245209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative analysis of how patients decide that they want risk-reducing mastectomy, and the implications for surgeons in responding to emotionally-motivated patient requests.
    Brown SL; Whiting D; Fielden HG; Saini P; Beesley H; Holcombe C; Holcombe S; Greenhalgh L; Fairburn L; Salmon P
    PLoS One; 2017; 12(5):e0178392. PubMed ID: 28552971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions of contralateral breast cancer: an overestimation of risk.
    Abbott A; Rueth N; Pappas-Varco S; Kuntz K; Kerr E; Tuttle T
    Ann Surg Oncol; 2011 Oct; 18(11):3129-36. PubMed ID: 21947590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.
    Parker PA; Peterson SK; Bedrosian I; Crosby MA; Shen Y; Black DM; Babiera G; Kuerer HM; Ying J; Dong W; Cantor SB; Brewster AM
    Ann Surg; 2016 Jan; 263(1):178-83. PubMed ID: 25822675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What quality-of-life issues do women with ductal carcinoma in situ (DCIS) consider important when making treatment decisions?
    Mercieca-Bebber R; King MT; Boxer MM; Spillane A; Winters ZE; Butow PN; McPherson J; Rutherford C
    Breast Cancer; 2017 Sep; 24(5):720-729. PubMed ID: 28247220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
    Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
    Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should the use of contralateral prophylactic mastectomy be increasing as it is?
    Wood WC
    Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contralateral Prophylactic Mastectomy: Challenging Considerations for the Surgeon.
    Angelos P; Bedrosian I; Euhus DM; Herrmann VM; Katz SJ; Pusic A
    Ann Surg Oncol; 2015 Oct; 22(10):3208-12. PubMed ID: 26259752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem?
    Sacchini V; Pinotti JA; Barros AC; Luini A; Pluchinotta A; Pinotti M; Boratto MG; Ricci MD; Ruiz CA; Nisida AC; Veronesi P; Petit J; Arnone P; Bassi F; Disa JJ; Garcia-Etienne CA; Borgen PI
    J Am Coll Surg; 2006 Nov; 203(5):704-14. PubMed ID: 17084333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.